114 related articles for article (PubMed ID: 25557864)
1. Associated factors of drug-drug interactions of highly active antiretroviral therapy: report from a referral center.
Farhoudi M; Khalili H; Karimzadeh I; Abbasian L
Expert Opin Drug Metab Toxicol; 2015 Apr; 11(4):471-9. PubMed ID: 25557864
[TBL] [Abstract][Full Text] [Related]
2. Incidence of antiretroviral drug-related problems in the treatment of HIV among hospitalized patients in the Hospital Santa Clara, Bogotá.
Badillo CA; Barrera LK; Arias G; Tribiño GF; Gamboa OA; García JC; Granada AM
Biomedica; 2019 Sep; 39(3):561-575. PubMed ID: 31584769
[TBL] [Abstract][Full Text] [Related]
3. A balance of risks for the treatment of the chronically HIV-infected asymptomatic individual.
Watson C; Fisher M
Clin Med (Lond); 2003; 3(3):212-6. PubMed ID: 12848253
[No Abstract] [Full Text] [Related]
4. Potential Drug Interactions in Terminally-Ill Cancer Patients, a Report from the Middle East.
Mahzoni H; Naghsh E; Sharifi M; Moghaddas A; Momenzadeh M; Moghaddas A
J Pain Palliat Care Pharmacother; 2023 Dec; 37(4):278-285. PubMed ID: 37712672
[TBL] [Abstract][Full Text] [Related]
5. Drug-Drug Interactions With Antiviral Agents in People Who Inject Drugs Requiring Substitution Therapy.
Meemken L; Hanhoff N; Tseng A; Christensen S; Gillessen A
Ann Pharmacother; 2015 Jul; 49(7):796-807. PubMed ID: 25902733
[TBL] [Abstract][Full Text] [Related]
6. Drug-drug interaction profile of the all-oral anti-hepatitis C virus regimen of paritaprevir/ritonavir, ombitasvir, and dasabuvir.
Menon RM; Badri PS; Wang T; Polepally AR; Zha J; Khatri A; Wang H; Hu B; Coakley EP; Podsadecki TJ; Awni WM; Dutta S
J Hepatol; 2015 Jul; 63(1):20-9. PubMed ID: 25646891
[TBL] [Abstract][Full Text] [Related]
7. Risk of drug resistance among persons acquiring HIV within a randomized clinical trial of single- or dual-agent preexposure prophylaxis.
Lehman DA; Baeten JM; McCoy CO; Weis JF; Peterson D; Mbara G; Donnell D; Thomas KK; Hendrix CW; Marzinke MA; Frenkel L; Ndase P; Mugo NR; Celum C; Overbaugh J; Matsen FA;
J Infect Dis; 2015 Apr; 211(8):1211-8. PubMed ID: 25587020
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic enhancement in HIV antiretroviral therapy: a comparison of ritonavir and cobicistat.
Renjifo B; van Wyk J; Salem AH; Bow D; Ng J; Norton M
AIDS Rev; 2015; 17(1):37-46. PubMed ID: 25586481
[TBL] [Abstract][Full Text] [Related]
9. Risk factors and mortality associated with resistance to first-line antiretroviral therapy: multicentric cross-sectional and longitudinal analyses.
Pinoges L; Schramm B; Poulet E; Balkan S; Szumilin E; Ferreyra C; Pujades-Rodríguez M
J Acquir Immune Defic Syndr; 2015 Apr; 68(5):527-35. PubMed ID: 25585301
[TBL] [Abstract][Full Text] [Related]
10. Tenofovir plasma concentrations related to estimated glomerular filtration rate changes in first-line regimens in African HIV-infected patients: ANRS 12115 DAYANA substudy.
Lê MP; Landman R; Koulla-Shiro S; Charpentier C; Sow PS; Diallo MB; Ngom Gueye NF; Ngolle M; Le Moing V; Eymard-Duvernay S; Benalycherif A; Delaporte E; Girard PM; Peytavin G;
J Antimicrob Chemother; 2015 May; 70(5):1517-21. PubMed ID: 25583749
[TBL] [Abstract][Full Text] [Related]
11. Serotonin reuptake inhibitors and breastfeeding: a systematic review.
Orsolini L; Bellantuono C
Hum Psychopharmacol; 2015 Jan; 30(1):4-20. PubMed ID: 25572308
[TBL] [Abstract][Full Text] [Related]
12. Cross-resistance to elvitegravir and dolutegravir in 502 patients failing on raltegravir: a French national study of raltegravir-experienced HIV-1-infected patients.
Fourati S; Charpentier C; Amiel C; Morand-Joubert L; Reigadas S; Trabaud MA; Delaugerre C; Nicot F; Rodallec A; Maillard A; Mirand A; Jeulin H; Montès B; Barin F; Bettinger D; Le Guillou-Guillemette H; Vallet S; Signori-Schmuck A; Descamps D; Calvez V; Flandre P; Marcelin AG;
J Antimicrob Chemother; 2015 May; 70(5):1507-12. PubMed ID: 25558077
[TBL] [Abstract][Full Text] [Related]
13. Long term reference change value of creatinine in HIV-positive patients with anti-retroviral therapy: A new tool in clinical practice.
Badiou S; Cournil A; Toubal S; Bargnoux AS; Dupuy AM; Fernandez C; Peyriere H; Reynes J; Cristol JP
Clin Biochem; 2015 Jun; 48(9):622-4. PubMed ID: 25601234
[TBL] [Abstract][Full Text] [Related]
14. The long-acting integrase inhibitor GSK744 protects macaques from repeated intravaginal SHIV challenge.
Radzio J; Spreen W; Yueh YL; Mitchell J; Jenkins L; García-Lerma JG; Heneine W
Sci Transl Med; 2015 Jan; 7(270):270ra5. PubMed ID: 25589631
[TBL] [Abstract][Full Text] [Related]
15. Maraviroc Failed to Control Progressive Multifocal Leukoencephalopathy-Associated IRIS in a Patient with Advanced HIV Infection.
Rodríguez M; Silva-Sánchez FA; Luna-Rivero C; Vega-Barrientos R; Alvarado-de la Barrera C; Reyes-Terán G
Case Rep Med; 2014; 2014():381480. PubMed ID: 25587282
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of etravirine combined with darunavir or other ritonavir-boosted protease inhibitors in HIV-1-infected patients: an observational study using pooled European cohort data.
Vingerhoets J; Calvez V; Flandre P; Marcelin AG; Ceccherini-Silberstein F; Perno CF; Mercedes Santoro M; Bateson R; Nelson M; Cozzi-Lepri A; Grarup J; Lundgren J; Incardona F; Kaiser R; Sonnerborg A; Clotet B; Paredes R; Günthard HF; Ledergerber B; Hoogstoel A; Nijs S; Tambuyzer L; Lavreys L; Opsomer M;
HIV Med; 2015 May; 16(5):297-306. PubMed ID: 25585664
[TBL] [Abstract][Full Text] [Related]
17. The clinical role and cost-effectiveness of long-acting antiretroviral therapy.
Ross EL; Weinstein MC; Schackman BR; Sax PE; Paltiel AD; Walensky RP; Freedberg KA; Losina E
Clin Infect Dis; 2015 Apr; 60(7):1102-10. PubMed ID: 25583979
[TBL] [Abstract][Full Text] [Related]
18. Differential Reduction in Monocyte Activation and Vascular Inflammation With Integrase Inhibitor-Based Initial Antiretroviral Therapy Among HIV-Infected Individuals.
Hileman CO; Kinley B; Scharen-Guivel V; Melbourne K; Szwarcberg J; Robinson J; Lederman MM; Mccomsey GA
J Infect Dis; 2015 Aug; 212(3):345-54. PubMed ID: 25583168
[TBL] [Abstract][Full Text] [Related]
19. Correlates and Escitalopram Treatment Effects on Sleep Disturbance in Patients with Acute Coronary Syndrome: K-DEPACS and EsDEPACS.
Kim JM; Stewart R; Bae KY; Kang HJ; Kim SW; Shin IS; Hong YJ; Ahn Y; Jeong MH; Yoon JS
Sleep; 2015 Jul; 38(7):1105-11. PubMed ID: 25581916
[TBL] [Abstract][Full Text] [Related]
20. New Perspectives of HIV/AIDS Therapy Study.
Lu DY; Lu TR; Che JY; Wu HY; Xu B
Recent Pat Antiinfect Drug Discov; 2014; 9(2):112-20. PubMed ID: 25578060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
